Cingulate Inc. (CING)
NASDAQ: CING · Real-Time Price · USD
4.050
-0.050 (-1.22%)
At close: Jun 27, 2025, 4:00 PM
4.060
+0.010 (0.25%)
After-hours: Jun 27, 2025, 7:58 PM EDT
Cingulate Market Cap
Cingulate has a market cap or net worth of $17.20 million as of June 27, 2025. Its market cap has increased by 253.49% in one year.
Market Cap
17.20M
Enterprise Value
12.76M
1-Year Change
253.49%
Ranking
Category
Stock Price
$4.05
Market Cap Chart
Since the IPO on December 8, 2021, Cingulate's market cap has decreased from $64.29M to $17.20M, a decrease of -73.25%. That is a compound annual growth rate of -31.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 17.41M | 6.94% |
| Dec 31, 2024 | 16.28M | 127.09% |
| Dec 29, 2023 | 7.17M | -36.62% |
| Dec 30, 2022 | 11.31M | -63.77% |
| Dec 31, 2021 | 31.21M | -51.44% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 713.81B |
| Johnson & Johnson | 365.75B |
| AbbVie | 329.95B |
| Novo Nordisk | 299.93B |
| UnitedHealth Group | 274.52B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 232.56B |
| AstraZeneca | 215.99B |